Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 3,281–3,288 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Pfizer Inc. Etrasimod Atopic dermatitis (AD) Phase 2b Oral Immunology
Pfizer Inc. Olorinab Irritable Bowel Syndrome Phase 2b Oral Gastroenterology
Pfizer Inc. Taldefgrobep alfa Obesity Phase 2 Ongoing Intramuscular Endocrinology
Pfizer Inc. CRDF-004 Metastatic colorectal cancer (mCRC) Phase 2 Data Released Oral Oncology
Pfizer Inc. BRAFTOVI (encorafenib) + MEKTOVI (binimetinib) - (PHAROS) Advanced Lung Cancer Phase 2 Data Released oral Oncology
Pfizer Inc. MET-233i + MET-097i Obesity Phase 2 Ongoing oral Endocrinology
Pfizer Inc. Disitamab vedotin plus toripalimab HER2-expressing muscle-invasive bladder cancer (MIBC) Phase 2 Ongoing Intravenous Oncology
Pfizer Inc. Ponsegromab Cancer-associated cachexia Phase 2 Trial Completed Intravenous Oncology
1…409410411412413…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.